The combination of GLP-1 receptor agonists (GLP-1 RAs) and insulin represents one of the most powerful treatment strategies for diabetes and obesity. However, it is also one of the most technically challenging. When these two medications are combined without careful planning, the risks of hypoglycemia, diabetic ketoacidosis (DKA), and other complications rise significantly. https://slimchecker.com/